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Abstract
Background: Accurate measurement of the incidence of diarrhoeagenic E. coli in patients with diarrhoea is
hindered by the current methods of detection and varies from country to country. In order to improve the
diagnosis of diarrhoeagenic E. coli (DEC), we developed a set of multiplex TaqMan real-time PCRs designed to
detect the respective pathogens from an overnight stool culture.
Methods: Over the period Jan. 2006 to Dec. 2006 all stool specimens (n = 1981) received were investigated for
EPEC and EAEC.
Results: Of these, 371 specimens had no growth of Enterobacteriaceae. Of the remaining 1610 specimens 144
(8,9%) were positive for EPEC and 78 (4,8%) positive for EAEC. Among the EPEC positive stool specimens 28 (19,4%)
were received from the tropical diseases unit, 49 (34%) from the paediatric dept. and 67 (46,5%) from the
remainder of the wards. The EAEC were distributed as follows: 39 (50%) - tropical diseases, 19 (24,4%) -paediatrics
and 20 (25,6%) other wards. Proportionately more EAEC and EPEC were found in children less than 3 years of age
than other age groups. In only 22,2% of the detected EPEC and 23% of EAEC was the investigation requested by
hospital staff.
Conclusions: This is, to our knowledge, the first study using a multiplex TaqMan PCR for the successful detection
of diarrhoeagenic E. coli. In conclusion, due to the high prevalence of DEC detected, investigation of EPEC and
EAEC should be recommended as a routine diagnostic test for patients with infectious diarrhoea.
Background
Infectious diarrhoea is a common complaint among
patients seeking medical advice and, despite progress in
diagnosis and treatment, remains one of the leading
causes of morbidity and mortality worldwide [1,2].
The spectrum of pathogens responsible for such infec-
tions varies with age and geographical location. A viral
pathogenesis is probably the main cause of diarrhoea in
industrialised countries [1,3], however systematic surveys
have shown that diarrhoeagenic E. coli (DEC) are a
common cause of diarrhoea in both developing and
developed countries. These pathogens, especially EAEC,
may routinely be underestimated as a cause of diarrhoea
due to under-representation of requests and difficulty
recognising these pathogens in the laboratory [4,5].
To date six categories of DEC have been defined on
the basis of specific virulence properties [6,7]. Entero-
toxigenic E. coli (ETEC) cause diarrhoea via secretion of
heat stable (ST) and/or heat labile (LT) enterotoxin.
Enteroinvasive E. coli (EIEC) strains are closely related
to Shigella spp. and the responsible genes are carried on
the pINV plasmid. Shiga-toxin producing or enterohae-
morrhagic E. coli (STEC/EHEC) cause both a non-
bloody diarrhoea as well as a haemorrhagic colitis which
may trigger haemolytic uraemic syndrome (HUS). The
virulence properties defining EHEC are the Shiga toxins
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city island LEE ("locus of enterocyte effacement”). Enter-
opathogenic E. coli (EPEC) show localised adherence to
the small intestine and cause a histopathological “attach-
ing and effacing (A/E) lesion” mediated through viru-
lence factors encoded within the LEE. Strains
additionally containing the EPEC adherence factor
(EAF) plasmid have been termed “typical” EPEC,
whereas strains that lack the EAF plasmid are referred
to as “atypical” EPEC. Enteroaggregative E. coli (EAEC
or EAggEC) was first described in 1987 [8] and has
been associated with acute diarrhoea in children, HIV
positive individuals, and as a cause of travellers’ diar-
rhoea [9]. Moreover it has been linked to persistent
diarrhoea and even growth retardation in children [10].
Numerous findings suggest that there is an inflamma-
tory process underlying the infection [11,12]. The PCR-
target used in this report is a sequence on the plasmid
pCVD432 on which the genes coding for the fimbrial
structure (aggregative adherence fimbria I) and further
virulence factors are located [13]. The sixth category is
the diffusely adherent E. coli (DAEC) in which the bac-
teria, unlike EAEC do not adhere to the host cells in
microcolonies but rather diffusely over the cell surface.
No PCR has been developed yet to detect DAEC strains.
Since DEC cannot be diagnosed adequately by culture
and biochemical criteria alone, identification of these
strains is difficult. Many PCR techniques detecting var-
ious genes coding for virulence traits of the different
categories of DEC have been reported [14-18]. We have
developed three new multiplex TaqMan PCR assays,
designed to be run in parallel, to detect ETEC, EIEC,
EHEC, EPEC and EAEC simultaneously.
In addition to many studies from developing countries
recent reports underline the importance of EPEC and
EAEC in developed countries [5,19-21]. In Germany
very limited data are available. Therefore the aim of this
study was to evaluate the local importance of EPEC and
EAEC in a German University hospital in relation to the
requesting clinical department and age group, using the
newly developed real-time PCR as a diagnostic tool.
Methods
Study population
From January 2006 to December 2006 a total of 1981
faecal samples received for Salmonella, Shigella and
Campylobacter spp. culture were included in the screen-
ing for EPEC and EAEC. Of these 371 specimens had
no growth of Enterobacteriaceae hence 1610 samples
w e r et e s t e df o rE P E Ca n dE A E Cb yu s eo ft h eP C R
method described below. Stool samples were obtained
from most departments of the University Hospital of
Düsseldorf, Germany. The patient age ranged from a
few days to 98 years.
DNA preparation
All faecal samples received were plated on MacConkey
Agar and incubated for 18 h at 37°C. A bacterial sus-
pension from all colonies was made by rinsing the entire
plate with 2 ml of sterile saline. The bacterial suspen-
sion was diluted to MacFarland Standard 1,0 (approx.
3*10
8 CFU/ml) using distilled water. This suspension
was heated at 95°C for 15 minutes. 2,5 μl (correspond-
ing to approximately 7,5*10
5 CFU) were applied directly
to the multiplex PCR. The remainder of the sample was
stored at -20°C.
TaqMan PCR
Three different multiplex TaqMan PCRs were designed
and were all run using the same time and temperature
settings on a Biorad iCycler system. A two step amplifi-
cation profile was used as follows: 95°C for 10 min. fol-
lowed by 45 cycles of 15 s. at 95°C and 60 s. at 60°C for
annealing and elongation. The PCR contained 10 pmol
of each primer, 2 pmol of the target probes, 5 pmol of
the internal inhibition control probe (all from Eurogen-
tec, Cologne, Germany), 100 copies of inhibition control
plasmid, 2,5 μl sample, 12,5 μl of No ROX PCR Master-
mix (Qiagen, Hilden, Germany) and was diluted with
distilled water to a final volume of 25 μl.
Two target sequences were used for EPEC amplifica-
tion: a 107 bp sequence of the enteropathogenic E. coli
adherence factor (EAF) plasmid [22] and a 189 bp long
fragment of the intimin gene (eae) within the locus of
enterocyte effacement based upon an alignment of var-
ious published intimin subtype sequences (designed with
support of TIB MOLBIOL, Berlin, Germany). The target
sequence for EAEC was a 152 bp sequence of the
pCVD432 plasmid [23]. The second multiplex PCR was
designed to detect ETEC and EIEC. Targets for ETEC
were a 107 bp fragment of the ST and a 113 bp
sequence of the LT gene. For EIEC a 107 bp sequence
of the virulence plasmid essential for invasiveness, pINV
was targeted. The third PCR detects EHEC by targeting
a 87 bp fragment of the shiga-toxin 1 (stx1) and a 82 bp
sequence of the shiga-toxin 2 (stx2) gene. All probes
were labelled with fluorophores and quenchers as listed
in Table 1. Isolates of sequenced pathogens served as
positive controls while a non pathogenic E. coli strain
(ATCC 25922) was used as negative control. Since the
sequences of pINV and stx1 are also present in shigella,
in all specimens positive for either of these an infection
due to shigella was excluded by culture.
PCR-based detection methods, especially from faecal
samples are prone to inhibition of amplification [24]. As
an internal control (IC) specimens were spiked with
synthesised nucleotide sequences using an unrelated
probe sequence from the retrotransposon Ninja from
Drosophila simulans (AB110070) in the pCR II-TOPO
Vector (Invitrogen, Karlsruhe, Germany) flanked by the
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tion of targeted template in a MacFarland standard 1,0
apathogenic E. coli suspension revealed reliable fluores-
cence signals to a mean number of 1,5 bacterial gen-
omes per 2,5 μl for all targets. No cross reactivity with
various bacteria (Streptococcus, Staphylococcus, Entero-
coccus, Pseudomonas, Klebsiella, Proteus, Citrobacter,
Salmonella, Yersinia, Campylobacter, Aeromonas caviae,
Clostridium difficile and Enterobacter spp.) other than
the known positivity with Shigella dysenteriae using the
EHEC PCR was detected.
Results
All stool samples were obtained from the University
Hospital of Düsseldorf. Altogether 144 (8,9%) specimens
were positive for EPEC and 78 (4,8%) positive for EAEC,
including 17 samples that were positive for both patho-
gens. An example of an amplification plot of a double
infection is shown in Fig. 1. From the samples positive
for EPEC only 7 (4,9%) were positive for both eae and
EAF (typical EPEC), making atypical EPEC the predomi-
nant pathotype. Five samples were positive for EAF
only. All eae positive specimens were additionally exam-
ined for the presence of stx1 and stx2 and were all nega-
tive. In comparison to these results Salmonella spp. was
found in 38 (2,4%), Campylobacter spp. in 39 (2,4%) and
Shigella spp. in only 1 (0,06%).
The data were divided into three groups depending on
the requesting department: the department for tropical
diseases, paediatrics and a last group of all the
Table 1 Primers and probes for multiplex TaqMan PCR
Target Primer or probe name Oligonucleotide sequence (5’®3’) Amplicon size/Accession nr.
Multiplex 1: (EPEC/EAEC)
EAF EP-1 for
EP-2 rev
EP-S probe
GTT CTT GGC GAA CAG GCT TGT C
TTA AGC CAG CTA CCA TCC ACC C
Cy5-AGT ACT GAC GTG CAG GTC GCC TGT TCG-BHQ-3
107 bp
X76137
eae EAE-S for
EAE-B1 rev
EAE-B2 rev
EAE-TM probe
ACT GGA CTT CTT ATT RCC GTT CTA TG
CTA AGC GGG TAT TGT TAC CAG A
CCT AAA CGG GTA TTA TCA CCA GA
ROX-AAT CCT GAT CAA TGA AGA CGT TAT AGC CCA-BBQ
189 bp*
Z11541/
AB040740
pCVD432 EA-1 for
EA-2 rev
EA-S probe
AGG TTT GAT ATT GAT GTC CTT GAG GA
TCA GCT AAT AAT GTA TAG AAA TCC GCT GTT
FAM-CAT GTT CCT GAG AGT GCA ATC CCA GAC ATT AC-TAMRA
152 bp
X81423
Multiplex 2: (ETEC/EIEC)
ST gene ST-1 for
ST-2 rev
ST-S probe
CTG GTT TTG ATT CAA ATG TTC GTG
TCC TGA GGG AAA GGT GAA AAA GAC
ROX-TTG ATT TCT TCA TAT TAC CTC CGG ACA TGG CA-BHQ-2
107 bp
M34916
LT gene LT-1 for
LT-2 rev
LT-S probe
AGC GGC GCA ACA TTT CAG
TTG GTC TCG GTC AGA TAT GTG ATT C
FAM-TCG AAG TCC CGG GCA GTC AAC ATA TAG A-TAMRA
113 bp
S60731
ipaH Ei-1 for
Ei-2 rev
Ei-S probe
GAA CTC AAA TCT TGC ACC ATT CA
CGT CCG TCC GAG AAC AAT TAA G
Cy5-ATC CCC GAC ACC GTT TGT GAG TTT CAC T-BHQ-3
107 bp
AY206439
Multiplex 3: (EHEC)
stx1 slt1-1 for
slt1-2 rev
slt1-S probe
CTT CCA TCT GCC GGA CAC ATA
ATT AAT ACT GAA TTG TCA TCA TCA TGC AT
ROX-AAG GAA ACT CAT CAG ATG CCA TTC TGG CA-BHQ-2
87 bp
Z36899
stx2 slt2-1 for
slt2-2 rev
slt2-S probe
GAC GTG GAC CTC ACT CTG AAC TG
TCC CCA CTC TGA CAC CAT CC
FAM-TAC TCC GGA AGC ACA TTG CTG ATT CGC-TAMRA
82 bp
L11079
Internal Control
Drosophila simulans + IC probe HEX-ATG CCT CTT CAC ATT GCT CCA CCT TTC CT-BHQ1 AB110070
+The bold, italic labelled primers also detect the internal control plasmid in the respective PCR
*Alignment of various intimin subtype sequences
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eases group consisted of 150 samples only but had a
relatively high positivity rate with 28 EPEC positive and
39 EAEC positive samples. 18,7% of all specimens tested
within this group were positive for EPEC and 26% for
EAEC. Most patients seen in this department have a tra-
vel history and, with the exception of only 4 patients, all
were between 18 and 65 years of age. From the paedia-
tric wards 458 specimens were tested and 49 EPEC posi-
tive and 19 EAEC positive samples were detected
showing an prevalence of 10,7% for EPEC and 4,1% for
EAEC. From the remaining 1002 samples from all other
departments 67 (6,7%) were tested positive for EPEC
and 20 (2%) positive for EAEC. Table 2 shows the
results.
Since most reports on DEC show different incidences
depending on age we divided the samples according to
age groups as seen in Fig. 2. A peak prevalence for
EPEC was found (16,3%) in the age group between one
and two years. In the age groups of patients below one
year of age and between two and five years the preva-
lence varied from 9,1% to 10,2%, which is slightly higher
than in the groups between five and 18 years (7,6%) and
the group above 65 years of age (4,9%). The prevalence
in the group between 18 and 65 years (10,2%) was unex-
pectedly high, but of the 74 positive samples 26 were
sent by the tropical diseases department, indicating a
history of travel. With one exception (one positive speci-
men in the age group below one year), all specimens
from the department of tropical diseases were from
patients over 18 years of age. For EAEC a clear peak
was seen in the age group between two and three years
with an prevalence of 14,5%. Below two years of age and
between three and five years the prevalence ranged from
1,3% up to 3,3%. None of these samples were from the
tropical diseases department. In the age groups between
five and 18 and 18 and 65 a smaller peak was found
with prevalence of 4,6% and 7% respectively. 1,7% of
EAEC positive specimens were from patients over 65.
The peak in the group between 18 and 65 years was
mostly due to samples from the department for tropical
diseases (36 out of 51). In the age group five to 18
years, one specimen and in the group over 65 years, two
specimens were received from this department.
In our hospital all stool specimens from children aged
up to one year are tested for EPEC routinely, however it
was noted that requests for DEC are very rarely made
for patients above this age. Therefore we looked at the
number of DEC cases found by routine investigations in
comparison to the total number of cases found by sys-
tematic screening of all specimens received. Table 2
shows the findings for EPEC and EAEC. 15 EPEC posi-
tive samples from children below one year of age were
detected by routine screening and of the positive results
for EPEC or EAEC in the group of samples from chil-
dren between one and five years of age none was
detected by routine request. In the age group between 5
and 18 years of age only one (EPEC positive) specimen
was actually requested by the paediatric department and
1 (EAEC positive) specimen from the department for
tropical diseases. Between 18 and 65 years a relatively
large number of positive results was found in screening
Figure 1 Amplification plot of a double infection with atypical EPEC and EAEC.
Table 2 Number of stool samples tested according to
department and positivity rate for EPEC and EAEC
Department tested EPEC (%) EAEC (%)
tropical diseases 150 28 (18,7) 39 (26,0)
paediatrics 458 49 (10,7) 19 (4,1)
others 1002 67 (6,7) 20 (2,0)
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positive and 15 (29,4%) EAEC positive specimens were
detected due to a specific request from the respective
department. Furthermore, except for three positive
EPEC specimens and one positive EAEC specimen, all
of the specimens were sent by the department for tropi-
cal diseases. In the group above 65 years in only two of
the specimens that were positive for EAEC was the
investigation routinely requested, again by the depart-
ment for tropical diseases.
Discussion
Detecting DEC relies greatly on PCR techniques and
many reports are available on procedures used to iden-
tify all categories of DEC [13-18,26]. Most of these tech-
niques however, are based on standard PCR. We have
developed a novel multiplex real-time PCR which, with
three reactions run parallel to one another, identifies the
5 major categories of DEC simultaneously. To our
knowledge this is the first reported use of a TaqMan
PCR, which provides both a convenient diagnostic tool
and avoids the risk of cross contamination due to post
amplification handling.
By rinsing all the colonies from the agar plate with
saline rather than picking representative colonies as has
been described in the literature, we were able to
increase the sensitivity of the PCR. This method is
quick, simple and inexpensive. The real-time PCR was
able to detect 1,5 genome equivalents per assay.
As reported by the Robert Koch Institute, Berlin, Ger-
many, of all reportable intestinal infections in 2006 in
Germany, DEC, excepting EHEC, was the fifth largest
group of pathogens after Norovirus, Rotavirus, Salmo-
nella and Campylobacter spp. In our study reported
here, the prevalence of EPEC (8,9%) and EAEC (4,8%)
exceeded those for salmonella and campylobacter, each
2,4%. It is possible that the incidence of EPEC and
EAEC throughout Germany is far higher than that
reported. This discrepancy may very well be due to the
low level of routine requests for DEC as we observed in
the study period in this hospital. Unfortunately no data
can be provided here to compare the incidence of DEC
to that of viral pathogens since in this study stool speci-
mens were not systematically tested for viral pathogens.
However, in the paediatric population (the age group
under 18 years in this study), many specimens were
additionally tested for viruses and out of 40 EPEC posi-
tive samples additionally tested for viruses, 16 were
additionally positive for rotavirus, norovirus or adeno-
virus. 4 specimens positive for EPEC were additionally
positive for Salmonella spp. (1) or Campylobacter spp.
(3). This leaves EPEC as the sole identified pathogen in
50% of all cases. EAEC was the only pathogen detected
in 45% of the samples in this age group. In nine cases
the specimen was positive for rotavirus, norovirus or
adenovirus as well, whereas in three samples Campylo-
bacter spp. was found as a co-infection and one speci-
men was tested positive for Salmonella spp. Even
though this study provides no systematic data on viral
testing we must assume that viral infections outnumber
the cases of diarrhoea due to DEC in children. It is pos-
sible that more stool samples were submitted for viral
detection only and thus the prevalence for EPEC and
EAEC found in this study may still be an underestima-
tion in this age group.
A strong association between EPEC and diarrhoea in
children has been reported [27], yet we also found a
relatively high prevalence for EPEC in older patients.
A large proportion of EPEC (and EAEC) infections
may well be associated with travel, since a high number
of positive specimens within the group between 18 and
65 years were obtained from the department for tropical
diseases. Concerning the association of atypical EPEC
with diarrhoea findings are contradictory [27-29], but it
continues to be the most prevalent pathotype of EPEC
found in industrialised countries [27,29,30], which we
also noted in our study. A subset of the heterogeneous
group of atypical EPEC has been found in patients with
bloody diarrhoea, (in some cases leading to HUS). They
resembled EHEC according to their serotype, virulence
profile and multilocus sequence types, leading to the
assumption that these strains might be EHEC that have
at some stage lost the shiga toxin gene during infection
[31]. Unusual in this study is the detection of EAF with-
out the eae gene as most often eae is found alone (atypi-
cal EPEC) or with EAF. It is questionable whether
strains positive for EAF but not for eae should be classi-
fied as EPEC and whether they actually are pathogenic.
Further investigation is required as to whether this is
due to a sequence variation within the intimin gene
Figure 2 The percent of specimens positive for EPEC (white
square) and EAEC (black square) in age groups compared to
all specimens received from patients in the respective age
group.
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other bacterial strains have acquired the EAF plasmid.
One limitation of this study is the inability of the
method to distinguish between those patients with a
double infection with two or more DEC and those
patients who are infected with a single bacterium carry-
i n gm o r et h a no n ev i r u l e n c eg e n e .B e c a u s ew eu s ea
pool of bacteria from an overnight culture, it is not pos-
sible to trace the result back to a single bacterial clone.
I nt h i ss t u d yw ef o u n d1 7s p e c i m e n sw h i c hw e r ep o s i -
tive for both EPEC and EAEC. In no case was the dis-
tinction between a single bacterium carrying both
factors or a double infection clinically relevant. Never-
theless, it would be interesting to determine the fre-
quency of multiple gene carriage by a single clone and
we are currently prospectively attempting to trace back
to the gene-carrying clone(s).
Conclusions
In our study we find the prevalence for EPEC and EAEC
to be unexpectedly high in Düsseldorf, and we conclude
that all patients with diarrhoeal disease should be routi-
nely tested for these pathogens, especially children
below the age of five, returning travellers and in those
specimens in which no other pathogen can be identified.
We also demonstrate the use of a novel multiplex PCR
for the detection of diarrhoeagenic E. coli from stool
specimens.
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